These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 18454589)

  • 1. Pharmacokinetic and pharmacodynamic alterations in the geriatric patient.
    Delafuente JC
    Consult Pharm; 2008 Apr; 23(4):324-34. PubMed ID: 18454589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic alterations in older people with dementia.
    Reeve E; Trenaman SC; Rockwood K; Hilmer SN
    Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):651-668. PubMed ID: 28460576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geriatric pharmacology for the dentist. An overview.
    Picozzi A; Neidle EA
    Dent Clin North Am; 1984 Jul; 28(3):581-93. PubMed ID: 6589185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions.
    Corsonello A; Pedone C; Incalzi RA
    Curr Med Chem; 2010; 17(6):571-84. PubMed ID: 20015034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug dosage in the elderly. Is it rational?
    Turnheim K
    Drugs Aging; 1998 Nov; 13(5):357-79. PubMed ID: 9829164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in drug disposition in older adults: a focus on geriatric syndromes.
    Maher D; Ailabouni N; Mangoni AA; Wiese MD; Reeve E
    Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):41-52. PubMed ID: 33078628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
    Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U
    Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic considerations in geriatric dentistry.
    Pyle MA; Tolbert SR
    Dent Clin North Am; 1994 Oct; 38(4):755-67. PubMed ID: 7805946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medications in older patients.
    Hobson M
    West J Med; 1992 Nov; 157(5):539-43. PubMed ID: 1309183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of pharmacokinetic-pharmacodynamic relationships in drug development].
    Bellissant E; Courcier-Duplantier S; Blin O;
    Therapie; 2002; 57(4):347-57. PubMed ID: 12422555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ambiguous relation between aging and adverse drug reactions.
    Gurwitz JH; Avorn J
    Ann Intern Med; 1991 Jun; 114(11):956-66. PubMed ID: 2024864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamic changes associated with aging and implications for drug therapy.
    Sera LC; McPherson ML
    Clin Geriatr Med; 2012 May; 28(2):273-86. PubMed ID: 22500543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically relevant drug-drug interactions among elderly people with dementia.
    Sönnerstam E; Sjölander M; Lövheim H; Gustafsson M
    Eur J Clin Pharmacol; 2018 Oct; 74(10):1351-1360. PubMed ID: 29967921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters.
    Smit C; De Hoogd S; Brüggemann RJM; Knibbe CAJ
    Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):275-285. PubMed ID: 29431542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medications affecting functional status in older persons.
    Corsonello A; Onder G; Maggio M; Corica F; Lattanzio F
    Curr Pharm Des; 2014; 20(19):3256-63. PubMed ID: 24050161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers, validation and pharmacokinetic-pharmacodynamic modelling.
    Colburn WA; Lee JW
    Clin Pharmacokinet; 2003; 42(12):997-1022. PubMed ID: 12959633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review.
    Himebauch AS; Kilbaugh TJ; Zuppa AF
    Expert Opin Drug Metab Toxicol; 2016 Oct; 12(10):1133-42. PubMed ID: 27322360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic-pharmacodynamic crisis in the elderly.
    ElDesoky ES
    Am J Ther; 2007; 14(5):488-98. PubMed ID: 17890940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating receptor theory in mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling.
    Ploeger BA; van der Graaf PH; Danhof M
    Drug Metab Pharmacokinet; 2009; 24(1):3-15. PubMed ID: 19252332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.